glp-1 ras list of approved and pending medications The expanding scope of GLP-1

There is limited evidence regarding the relationship between high vitamin B12 levels and blood sugar regulation

Untreated obesity increases the risk of cardiovascular disease, type 2 diabetes, obstructive sleep apnea, metabolic-associated steatotic liver disease (fatty liver), chronic kidney disease, multiple cancers (endometrial, esophageal, liver, kidney, breast), osteoarthritis, and dementia

One commenter suggested using clusters but maintaining cost and frequency thresholds, further suggesting using eligibility for Transitional Pass-Through payment as one criterion by which to identify instances where a code cluster would be appropriate for an expanded complexity adjustment

& Kiehn, O

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), which are widely used for the treatment of T2DM and promote weight loss in individuals with obesity, have demonstrated significant cardiovascular benefits